Renal Cancer - Results from #5600

Role of IL-2 in cancer immunotherapy August 4, 2016

[Cancer genetic screening for patient with multiple renal tumors: What is the current practice for what results?] August 3, 2016

Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Practical Clinical Implications of Pharmacologic Features August 2, 2016

Surveillance following surgery for nonmetastatic renal cell carcinoma August 1, 2016

Molecular profiling of renal cell carcinoma: building a bridge toward clinical impact August 1, 2016

Assessment of Efficacy, Safety, and Quality of Life of 124 Patients Treated With Axitinib as Second-Line Therapy for Metastatic Renal-Cell Carcinoma: Experience in Real-World Clinical Practice in Japan August 1, 2016

Contemporary Treatment of Metastatic Renal Cell Carcinoma August 1, 2016

Individualized pazopanib dosing: a prospective feasibility study in cancer patients August 1, 2016

Advances in treatment of metastatic renal cell carcinoma July 31, 2016

Expression of miRNA-21 and miRNA-221 in clear cell renal cell carcinoma (ccRCC) and their possible role in the development of ccRCC July 28, 2016

[Diagnosis and treatment of isolated pancreatic metastases from renal clear cell carcinoma: Report of a case and review of literature] July 22, 2016

Is there a difference in clinicopathological outcomes of renal tumor between young and old patients? A multicenter matched-pair analysis July 22, 2016

CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma July 22, 2016

Validation of VEGFR1 rs9582036 as predictive biomarker in metastatic clear-cell renal cell carcinoma patients treated with sunitinib July 21, 2016

Lack of TMEM27 expression is associated with postoperative progression of clinically localized conventional renal cell carcinoma July 21, 2016

Body Mass Index and Survival in a Prospective Randomized Trial of Localized High Risk Renal Cell Carcinoma July 20, 2016

Clinical and Histologic Features of Lichenoid Mucocutaneous Eruptions Due to Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Immunotherapy July 20, 2016

Severe perioperative bleeding in renal cell carcinoma after elective pericardiocentesis associated left ventricular puncture: case report July 19, 2016

Novel drugs that target the metabolic reprogramming in renal cell cancer July 18, 2016

Efficient generation of patient-matched malignant and normal primary cell cultures from clear cell renal cell carcinoma patients: clinically relevant models for research and personalized medicine July 17, 2016

Page 281 of 456